U.S. Therapeutic Interventional Cardiology Devices Market US$ 2.64 Billion by 2021

The U.S. therapeutic interventional cardiology devices market expected to reach US$ 2.64 billion by 2021, growing at CAGR 0.2% over the forecast period 2017-2021.

For more details on U.S. Therapeutic Interventional Cardiology Devices Market by Devices Type (Coronary Stent Systems, Percutaneous Transluminal Coronary Angioplasty Devices, Coronary Atherectomy Systems - Laser Atherectomy Systems, Mechanical Atherectomy Systems, ¬Transcatheter Septal Defect Repair Devices, ¬Coronary Thrombectomy Systems) and Forecast 2017-2021, contact us at https://www.ihealthcareanalyst.com/contact/

The global U.S. therapeutic interventional cardiology devices market research report provides market size (Revenue USD Million 2014 to 2021), procedure volumes, market share analysis, growth trends and forecast (CAGR%, 2017 to 2021). In addition, the U.S. therapeutic interventional cardiology devices market report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.

Major players operating in the global therapeutic interventional cardiology devices market and profiled in this report include Abbott Laboratories, Inc., B. Braun Melsungen AG, Bayer AG, Boston Scientific Corporation, BVM Medical Ltd., Cardiovascular Systems Inc., Cook Medical, Inc., C.R. Bard, Inc., Edwards Lifesciences, Getinge Group, iVascular, Johnson & Johnson (Cordis Corporation/ Cardinal Health, Inc.), Kyoto Medical Planning Corporation Ltd., Lepu Medical Technology, Medtronic, Inc., Merit Medical Systems, Inc., Siemens AG, Smiths Medical, Spectranetics Corp., Terumo Corporation, Vascular Solutions, Inc., and W. L. Gore & Associates.

1. Device Type
1.1. Coronary Stent Systems
1.2. Percutaneous Transluminal Coronary Angioplasty (PTCA) Devices
1.3. Coronary Atherectomy Systems
1.3.1. Laser Atherectomy Systems
1.3.2. Mechanical Atherectomy Systems
1.4. ¬Transcatheter Septal Defect Repair Devices
1.5. ¬Coronary Thrombectomy Systems

2. Company Profiles
2.1. Abbott Laboratories, Inc.
2.2. B. Braun Melsungen AG
2.3. Bayer AG
2.4. Boston Scientific Corporation
2.5. BVM Medical Ltd.
2.6. Cardiovascular Systems Inc.
2.7. Cook Medical, Inc.
2.8. C.R. Bard, Inc.
2.9. Edwards Lifesciences
2.10. Getinge Group
2.11. iVascular
2.12. Johnson & Johnson (Cordis Corporation/ Cardinal Health, Inc.)
2.13. Kyoto Medical Planning Corporation Ltd.
2.14. Lepu Medical Technology
2.15. Medtronic, Inc.
2.16. Merit Medical Systems, Inc.
2.17. Siemens AG
2.18. Smiths Medical
2.19. Spectranetics Corp.
2.20. Terumo Corporation
2.21. Vascular Solutions, Inc.
2.22. W. L. Gore & Associates

To request Table of Contents and Sample Pages of this report, contact us: https://www.ihealthcareanalyst.com/contact/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare IT, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.